Atlas Trials

Shuhong Yi

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shuhong Yi

RecordFirmDate
Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation (NCT05833126)Shuhong Yi2023-12-03

Track Shuhong Yi automatically

Every clearance here is in the API, with alerts when new ones post.